Abstract
Absorption of 125I-NPH insulin (125I-isophane insulin) (40 IU/ml) was studied in eight diabetics given 50% and 150% of their normal daily dose of insulin. Insulin absorption correlated with plasma insulin (r = 0.97, p < 0.001) and blood glucose (r = -0.87, p < 0.01) concentrations. Absorption was slower at higher doses, so that trebling the insulin dose only doubled the amount absorbed over the first 24 hours. The plasma elimination half time (t 1/2 ) of insulin was about five minutes. Thus, the disappearance of radiolabelled insulin is a reliable and quantitative index of insulin absorption; subcutaneous degradation, if present, is minimal and constant. Changes in dose of intermediate-acting insulin further increases the large variation in insulin absorption. This implies that minor adjustments of intermediate insulin dosage are probably futile.
Cite
CITATION STYLE
Lauritzen, T., Pramming, S., Gale, E. A. M., Deckert, T., & Binder, C. (1982). Absorption of isophane (NPH) insulin and its clinical implications. British Medical Journal, 285(6336), 159–162. https://doi.org/10.1136/bmj.285.6336.159
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.